| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Descriptive Information Fields | |||||
| Brief Title † | A Survey Study to See if Patients Diagnosed With Parkinson's Disease Have Higher Incidence of Melanoma | ||||
| Official Title † | A Survey to Assess the Incidence and Characteristics of Melanoma in Parkinson's Disease Patients | ||||
| Brief Summary | Patients with Parkinson's disease will be seen by a dermatologist who will biopsy any suspicious skin lesions. |
||||
| Detailed Description | |||||
| Study Phase | |||||
| Study Type † | Observational | ||||
| Study Design † | Other | ||||
| Primary Outcome Measure † | |||||
| Secondary Outcome Measure † | |||||
| Condition † | Parkinsons Disease Malignant Melanoma |
||||
| Intervention † | |||||
| MEDLINE PMIDs | |||||
| Links | |||||
| Recruitment Information Fields | |||||
| Recruitment Status † | Completed | ||||
| Enrollment † | 2106 | ||||
| Start Date † | January 2003 | ||||
| Completion Date | September 2003 | ||||
| Eligibility Criteria † | Inclusion Criteria: Confirmed diagnosis Parkinson's disease Patient able and willing to give informed consent Patient must not be taking any investigational drug at the time of enrollment Exclusion Criteria: |
||||
| Gender | Both | ||||
| Ages | |||||
| Accepts Healthy Volunteers | No | ||||
| Contacts †† | |||||
| Location Countries † | United States, Canada | ||||
| Administrative Information Fields | |||||
| NCT ID † | NCT00203008 | ||||
| Organization ID | EP002 | ||||
| Secondary IDs †† | |||||
| Study Sponsor † | Teva Pharmaceutical Industries | ||||
| Collaborators †† | |||||
| Investigators † |
|
||||
| Information Provided By | Teva Pharmaceutical Industries | ||||
| Verification Date | December 2007 | ||||
| First Received Date † | September 13, 2005 | ||||
| Last Updated Date | December 11, 2007 | ||||
|
